Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Q4 2023 vs. Q3 2023
How the institutions holding Apollomics Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 18.1M | 8.85M | −9.24M (−51.1%) |
| Value | $67.8M | $8.54M | −$59.2M (−87.4%) |
New holders (6)
Institutions that held Apollomics Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 54,722 | $52.8K | 0.00% |
| UBS Group AG | 32,136 | $31.0K | 0.00% |
| Bensler, LLC | 25,088 | $24.2K | 0.00% |
| Commonwealth Equity Services, LLC | 20,000 | $19.0K | 0.00% |
| Zullo Investment Group, Inc. | 14,853 | $14.3K | 0.01% |
| Tower Research Capital LLC (TRC) | 13 | $13 | 0.00% |
Sold out (3)
Institutions that held Apollomics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 13,935 | $52.2K |
| Barclays PLC | 905 | $3.39K |
| Royal Bank of Canada | 151 | $1.00K |